(April 28, 2009) … Tosoh’s G7 HPLC Analyzer tests both beta thalassemia and hemoglobin A1c in one compact benchtop analyzer. Features include: stable HbA1c results in 2.2 minutes, β-thalassemia results in less than 8 minutes, quantification of HbF and HbA2, multi-functional STAT sample position, presumptive ID of hemoglobinopathies, inventory management system, user-friendly software, compact size, NGSP certified.
For more information, go to G7 HPLC Analyzer
]]>
Beta Thalassemia Testing by Tosoh
April 3, 2009 - Beta thalassemia testing video describes process of switching to Beta thalassemia test mode on G7 HPLC Analyzer. The Tosoh G7 Automated HPLC Analyzer has both hemoglobin A1c and Beta-thalassemia programs to provide full patient profile. The Beta-thalassemia program quantifies hemoglobins F and A2, which are used in screening for Beta-thalassemia. In addition, the Beta-thalassemia program is used for presumptive identification of hemoglobins S, C and D and for screening for other hemoglobinopathies.
HPLC is the preferred methodology for hemoglobinopathy screening and since the G7 can be used for both hemoglobin A1c and Beta-thalassemia testing, it is 2 instruments in 1! The G7 provides time and labor-savings with primary tube sampling, automated cap piercing and positive sample identification. Most importantly, with less than 2% CVs the G7 offers a high level of both precision and accuracy, and is NGSP-certified.
Switching between the hemoglobin A1c and Beta-thalassemia programs is very easy, simple and fast. Just remove the hemoglobin A1c reagents, replace them with the Beta-thalassemia reagents, and let the instrument do the rest. Once the buffers and column have been changed, the system is automatically primed and is ready to perform analysis within minutes.
]]>